ITH response to CPS decision
ITH Pharma has now extended contracts on both the Berkshire and Scottish frameworks for a further 12 months.
The Berkshire framework currently covers up to 29 hospitals with the potential to supply up to 27 different PN product lines.
The Scottish framework covers up to 25 hospitals at present, offering up to 65 chemotherapy lines.
Both agreements will run up to the beginning of 2019.
These extensions are due to the continued quality service ITH Pharma provides. Since our launch back in 2008 our reputation has enabled us to continue supplying more NHS Trusts across the UK.
Related posts
